Seoul, South Korea

Sung-Uk Chung

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.5

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Sung-Uk Chung in Anti-Inflammatory and Anti-Angiogenic Research

Introduction

Sung-Uk Chung is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory and anti-angiogenic compositions. With a total of 2 patents, his work has the potential to impact various medical treatments.

Latest Patents

Chung's latest patents include an "Anti-inflammatory composition containing macrolactin A and a derivative thereof as active ingredients." This invention focuses on the anti-inflammatory properties of macrolactin compounds, which are derived from a novel strain of KJS-2 (KCCM10769P). The compounds have been shown to effectively suppress the expression of inducible nitric oxide synthetase (iNOS) and cyclooxygenase-2 (COX-2), which are crucial in the formation of inflammatory mediators. Additionally, these compounds inhibit the production of nitric oxide (NO) and prostaglandin E2 (PGE2), thereby providing excellent anti-inflammatory agents.

Another significant patent is the "Anti-angiogenic composition containing macrolactin A and a derivative thereof as active ingredients." This invention highlights the ability of macrolactin compounds to suppress angiogenesis in vivo. The potential applications of this composition include the prevention and treatment of diseases associated with angiogenesis.

Career Highlights

Sung-Uk Chung is affiliated with Daewoo Pharmaceutical Industries Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research focuses on harnessing the properties of macrolactin compounds to develop effective treatments for inflammatory and angiogenic diseases.

Collaborations

Chung has collaborated with notable colleagues, including Young-Hoon Ji and Dong-Hee Kim. Their combined expertise has contributed to the advancement of research in the field of pharmaceuticals.

Conclusion

Sung-Uk Chung's innovative work in developing anti-inflammatory and anti-angiogenic compositions showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in treatment options for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…